MedPath

Rehabilitation of Adolescents and Young Adults With Congenital Heart Diseases

Not Applicable
Completed
Conditions
Heart Defects, Congenital
Adolescent
Young Adult
Interventions
Other: Cardiac rehabilitation
Registration Number
NCT03690518
Lead Sponsor
University Hospital, Montpellier
Brief Summary

The investigators aim to measure the impact of a rehabilitation program in congenital cardiology in terms of health related quality of life. The orginality of the rehabilitation program consists in its design : initial hospitalizationfor a short period of time (5 days) at the rehabilitation center, followed by 11 weeks of rehabilitation at home under the supervision of a specialized sports trainer.

Detailed Description

Adolescents and adults with congenital heart disease (CHD) have reduced exercise capacity compared to the general population, even for "simple" heart disease.

Regular physical activity is known to reduce the risk of acquired heart disease.

Cardiac rehabilitation programs have been largely developed to manage adult coronary and heart failure patients, which is not yet the case routinely in patients, adults and children, carriers of DC.

The investigators assume that patients who participate in this program will improve their quality of life compared to controls.

The orginality of the rehabilitation program consists in its design : initial hospitalizationfor a short period of time (5 days) at the rehabilitation center, followed by 11 weeks of rehabilitation at home under the supervision of a specialized sports trainer .

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
142
Inclusion Criteria
  • Patient aged 13 to 25 years included
  • With a congenital heart diseases (CHD) as defined in the international CHD classification.
  • Recent (< 3 months) cardio-pulmonary exercise test (CPET)with maximum oxygen uptake (VO2max) <80% of theoretical values and/or first ventilatory anaerovic threshold (VAT) <55% of VO2max.
  • Consent of the adult patient or the parents or legal guardians of the minor patient.
  • Beneficiary of the social security scheme.
Exclusion Criteria
  • Uncontrolled arrhythmia.
  • Cardiac surgery planned during the rehabilitation program.
  • Severe musculoskeletal disorders.
  • Severe intellectual disability that does not allow the quality of life questionnaire to be completed.
  • Pregnancy.
  • Patient who already underwent cardiac rehabilitation in the last 24 months.
  • All medical contraindications to perform a cardiorespiratory stress test.
  • Uncontrolled heart failure (NYHA IV)
  • Obesity (BMI > 30)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
RehabilitaitonCardiac rehabilitationCardiac rehabilitation: Rehabilitation will have a regular follow-up with intervention (rehabilitation program)
Primary Outcome Measures
NameTimeMethod
Quality of life score (PedsQL, 24 items), range score from 0 to 100, higher score indicating better quality of life.follow up of patients over 12 months

Evolution of the PedsQL 4.0 self-reported scores from month 0 to month 12

Secondary Outcome Measures
NameTimeMethod
Peak oxygen uptake (VO2max, ml/kg/min)Month 0 and Month 12
ventilatory anaerobic threshold (VAT, ml/kg/min)Month 0 and Month 12
cardiac eventsMonth 0 and Month 12

number of consultation in cardiology, number of hospitalization in cardiology, number of cardiovascular events

physical activity scoringMonth 0 and Month 12

Score of physical activity (Ricci and Gagnon questionnaire, 9 items, total range score from 6 to 45, higher score indicating a higher level of physical activity)

Cardiac output during exerciseMonth 0 and Month12

Variation of cardiac output during exercise tests measured by impedance measurement (Physioflow)

functional NYHA classMonth 0 and Month 12

NYHA functional class= New York Association functional class from the World Health Organization

knowledge of the diseaseMonth 0 and Month 12

Disease knowledge questionnaire (Leuven questionnaire, 34 items, total range score from 0 to 100, a higher score indicating better knowledge)

Trial Locations

Locations (17)

Caremeau - Nimes University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Nรฎmes, France

Pasteur Clinic

๐Ÿ‡ซ๐Ÿ‡ท

Toulouse, France

Haut Lรฉvรชques - Bordeaux University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Bordeaux, France

Gabriel Montpied Hospital- Clermont Ferrand University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Clermont-Ferrand, France

Brest University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Brest, France

Marie Lannelongue Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Le Plessis-Robinson, France

La Timone- Public Assistance - Marseille hospitals

๐Ÿ‡ซ๐Ÿ‡ท

Marseille, France

Necker - Sick Children Hospital - Paris

๐Ÿ‡ซ๐Ÿ‡ท

Paris, France

Grenoble Alpes University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Grenoble, France

Children and Mother Hospital - Limoges University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Limoges, France

Liberal Cabinet Massy

๐Ÿ‡ซ๐Ÿ‡ท

Massy, France

Nice University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Nice, France

La Miletrie -Poitier University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Poitiers, France

Children Hospital - Toulouse University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Toulouse, France

Saint-Pierre Institute

๐Ÿ‡ซ๐Ÿ‡ท

Palavas-les-Flots, France

Barbois Hospital - Nancy University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Vandล“uvre-lรจs-Nancy, France

Arnaud de Villeneuve - University Hospital

๐Ÿ‡ซ๐Ÿ‡ท

Montpellier, France

ยฉ Copyright 2025. All Rights Reserved by MedPath